Insulin degluderc:A new generation of ultra-long-acting basal insulin analogue

( views:149, downloads:0 )
Author:
JI Li-nong()
Journal Title:
CHINESE JOURNAL OF DIABETES
Issue:
Volume 19, Issue 08, 2011
DOI:
10.3969/j.issn.1006-6187.2011.08.024
Key Word:

Abstract:

  • [1]Yang W,Lu J,Weng J,et al.Prevalence of diabetes among men and women in China.N Engl J Med,2010,362:1090-1101.
  • [2]The Diabetes Control and Complications Trial Research Group.The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.N Engl J Med,1993,329:977-986.
  • [3]Nathan DM,Cleary PA,Backlund JY,et al.Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes.N Engl J Med,2005,353:2643-2653.
  • [4]UK Prospective Diabetes Study(UKPDS)Group.Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes(UKPDS 33).Lancet 1998;352(9131):837-853.
  • [5]Holman RR,Paul SK,Bethel MA,et al.10-year follow-up of intensive glucose control,in type 2 diabetes.N Engl J Med,2008,359:1577-1589.
  • [6]Jonassen IB,Havelund S,Ribel U,et al.Insulin Degludec Is a New Generation Ultra-Long Acting Basal Insulin with a Unique Mechanism of Protraction Based on Multi-Hexamer Formation.Diabetes,2010,59(Suppl.1):All:(39-OR).
  • [7]Heise T,Hermanskl L,Nosek L,et al.Insulin degludec:less pharmacodynamic variability than insulin glargine under steady state conditions.Diabetologia 2010;53(Suppl.1):S387(Poster 971)
  • [8]Birkeland KI,Home PD,Wendisch U,et al.Insulin degludec in type Ⅰ diabetes:a randomized controlled trial of a new-generation ultra-long-acting insulin compared with insulin glargine.Diabetes Care,2011,34:661-665.
  • [9]Zinman B,Fulcher G,Rao PV,et al.Insulin degludec,an ultra-long-acting basal insulin,once a day or three times a week versus insulin glargine once a day in patients with type 2 diabetes:a 16-week,randomised,open-label,phase 2 trial.Lancet,2011,377:924-931.
WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn